Biology of Blood and Marrow Transplantation
Volume 15, Issue 9 , Pages 1049-1059 , September 2009

Hepatitis B Virus Reactivation following Allogeneic Hematopoietic Stem Cell Transplantation

  • Sarah P. Hammond

      Affiliations

    • Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts
    • Dana-Farber Cancer Institute, Boston, Massachusetts
    • Harvard Medical School, Boston, Massachusets
    • Corresponding Author InformationCorrespondence and reprint requests: Sarah P. Hammond, MD, Brigham and Women's Hospital, 75 Francis Street, PBB-A4, Boston, MA 02115.
    • ,
  • Anne Marie Borchelt

      Affiliations

    • Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts
    • ,
  • Chinweike Ukomadu

      Affiliations

    • Dana-Farber Cancer Institute, Boston, Massachusetts
    • Harvard Medical School, Boston, Massachusets
    • Division of Gastroenterology, Brigham and Women's Hospital, Boston, Massachusetts
    • ,
  • Vincent T. Ho

      Affiliations

    • Dana-Farber Cancer Institute, Boston, Massachusetts
    • Harvard Medical School, Boston, Massachusets
    • Division of Medical Oncology, Brigham and Women's Hospital, Boston, Massachusetts
    • ,
  • Lindsey R. Baden

      Affiliations

    • Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts
    • Dana-Farber Cancer Institute, Boston, Massachusetts
    • Harvard Medical School, Boston, Massachusets
    • ,
  • Francisco M. Marty

      Affiliations

    • Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts
    • Dana-Farber Cancer Institute, Boston, Massachusetts
    • Harvard Medical School, Boston, Massachusets

Received 2 April 2009 ,Accepted 4 May 2009.

References 

  1. World Health Organization. http://www.who.int/mediacentre/factsheets/fs204/en/index.html. Accessed April 27, 2009.
  2. Lau GKK, Liang R, Chiu EKW, Lee CK, Lam SK. Hepatic events after bone marrow transplantation in patients with hepatitis B infection: a case controlled study. Bone Marrow Transplant. 1997;19:795–799
  3. Hui CK, Lie A, Au WY, et al. A long-term follow-up study on hepatitis B surface antigen-positive patients undergoing allogeneic hematopoietic stem cell transplantation. Blood. 2005;106:464–469
  4. Ustun C, Koc H, Karayalcin S, et al. Hepatitis B virus infection in allogeneic bone marrow transplantation. Bone Marrow Transplant. 1997;20:289–296
  5. Chen PM, Fan S, Liu JH, et al. Reactivation of hepatitis B virus in two chronic GVHD patients after transplant. Int J Hematol. 1993;58:183–188
  6. Martin BA, Rowe JM, Kouides PA, DiPersio JF. Hepatitis B reactivation following allogeneic bone marrow transplantation: case report and review of the literature. Bone Marrow Transplant. 1995;15:145–148
  7. Dhedin N, Douvin C, Kuentz M, et al. Reverse seroconversion of hepatitis B after allogeneic bone marrow transplantation. Transplantation. 1998;66:616–619
  8. Iwai K, Tashima M, Itoh M, et al. Fulminant hepatitis B following bone marrow transplantation in an HBsAg-negative, HBsAb-positive recipient; reactivation of dormant virus during the immunosuppressive period. Bone Marrow Transplant. 2000;25:105–108
  9. Sakamaki H, Sato Y, Mori SI, et al. Hepatitis B virus reactivation in a patient with chronic GVHD after allogeneic peripheral blood stem cell transplantation. Int J Hematol. 2001;74:342–346
  10. Goyama S, Kanda Y, Nannya Y, et al. Reverse seroconversion of hepatitis B virus after hematopoietic stem cell transplantation. Leuk Lymphoma. 2002;43:2159–2163
  11. Seth P, Alrajhi AA, Kagevi I, et al. Hepatitis B virus reactivation with clinical flare in allogeneic stem cell transplants with chronic graft-versus-host disease. Bone Marrow Transplant. 2002;30:189–194
  12. Knoll A, Boehm S, Hahn J, Holler E, Jilg W. Reactivation of resolved hepatitis B virus infection after allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant. 2004;33:925–929
  13. Kempinska A, Kwak EJ, Angel JB. Reactivation of hepatitis B infection following allogeneic bone marrow transplantation in a hepatitis B-immune patient: case report and review of the literature. Clin Infect Dis. 2005;41:1277–1282
  14. Onozawa M, Hashino S, Izumiyama K, et al. Progressive disappearance of anti-hepatitis B surface antigen antibody and reverse seroconversion after allogeneic hematopoietic stem cell transplantation in patients with previous hepatitis B virus infection. Transplantation. 2005;79:616–619
  15. Francisci D, Aversa F, Coricelli V, et al. Prevalence, incidence and clinical outcome of hepatitis B virus and hepatitis C virus hepatitis in patients undergoing allogeneic hematopoietic stem cell transplantation between 2001 and 2004. Haematologica. 2006;91:980–982
  16. Knoll A, Boehm S, Hahn J, Holler E, Jilg W. Long-term surveillance of haematopoietic stem cell recipients with resolved hepatitis B: high risk of viral reactivation even in a recipient with a vaccinated donor. J Viral Hepat. 2007;14:478–483
  17. Kaloyannidis P, Batsis I, Yannaki E, et al. Allografted recipients immunized against hepatitis B virus are at high risk of gradual surface antibody (HBsAb) disappearance post transplant, regardless of adoptive immunity transfer. Biol Blood Marrow Transplant. 2007;13:1049–1056
  18. Fong TL, DiBisceglie AM, Gerber MA, Waggoner JG, Hoofnagle JH. Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis B. Hepatology. 1993;18:1313–1318
  19. Michalak TI, Pasquinelli C, Guilhot S, Chisari FV. Hepatitis B virus persistence after recovery from acute viral hepatitis. J Clin Invest. 1994;93:230–239
  20. Picardi M, DeRosa G, Selleri C, Pane F, Rotoli B, Muretto P. Clinical relevance of intrahepatic hepatitis B virus DNA in HBsAg-negative HBcAb-positive patients undergoing hematopoietic stem cell transplantation for hematological malignancies. Transplantation. 2006;82:141–142
  21. Ciesek S, Helfritz FA, Lehmann U, et al. Persistence of occult hepatitis B after removal of the hepatitis B virus-infected liver. J Infect Dis. 2008;197:355–360
  22. Lok ASF, McMahon BJ. Chronic hepatitis B. Hepatology. 2007;45:507–539
  23. Sorrell MF, Belongia EA, Costa J, et al. National Institutes of Health consensus development conference statement: management of hepatitis B. Ann Intern Med. 2009;150:104–110
  24. Keeffe EB, Dieterich DT, Han SB, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update. Clin Gastroenterol Hepatol. 2008;6:1315–1341
  25. Dienstag JL. Hepatitis B virus infection. N Engl J Med. 2008;359:1486–1500
  26. Przepiorka D, Weisdorf D, Martin P, et al. 1994 consensus conference on acute GVHD grading. Bone Marrow Transplant. 1995;15:825–828
  27. Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man. Am J Med. 1980;69:204–217
  28. Mast EE, Weinbaum CM, Fiore AE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep. 2006;55:1–33
  29. American Association of Blood Banks. http://www.aabb.org/AABBContent/Templates/AABBSub.aspx?NRMODE=Published&NRNODEGUID=%7b3A25F398-BFFA-4909-9257-B673AD063A2C%7d&NRORIGINALURL=%2fContent%2fAbout_Blood%2fFAQ%2fbloodfaq%2ehtm&NRCACHEHINT=NoModifyGuest#a9. Accessed March 31, 2009.
  30. Marty FM, Bryar J, Browne SK, et al. Sirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysis. Blood. 2007;110:490–500
  31. Ma S-H, Au W-Y, Ng IOL, et al. Role of liver biopsy in the management of liver dysfunction after hematopoietic stem-cell transplantation in a hepatitis B virus-prevalent patient population. Transplantation. 2003;76:169–176
  32. Onozawa M, Hashino S, Darmanin S, et al. HB vaccination in the prevention of viral reactivation in allogeneic hematopoetic stem cell transplantation recipients with previous HBV infection. Biol Blood Marrow Transplant. 2008;14:1226–1230

 Financial disclosure: See Acknowledgments on page 1058.

PII: S1083-8791(09)00219-5

doi: 10.1016/j.bbmt.2009.05.001

Biology of Blood and Marrow Transplantation
Volume 15, Issue 9 , Pages 1049-1059 , September 2009

Article Tools